Birt-hogg-dube syndrome

A harmful change in the FLCN gene (folliculin) is the underlying cause of Birt-Hogg-Dubé syndrome, usually inherited in an autosomal dominant way, though it can also arise for the first time in a family. If a parent carries the change, each child has a 50% chance of inheriting it, and the features can vary widely even within the same family. Some risks are written in our DNA, passed down through families. While environment and lifestyle don’t cause Birt-Hogg-Dubé syndrome, they can shape how it shows up; smoking and pressure changes from scuba diving or high‑altitude travel can raise the chance of a collapsed lung in people with lung cysts. General kidney health factors—such as smoking, high blood pressure, and excess weight—are linked to kidney cancer in the broader population, so healthy routines can’t remove the inherited risk in Birt-Hogg-Dubé syndrome but they support overall kidney and heart health and can prompt earlier checks if early symptoms of Birt-Hogg-Dubé syndrome appear.

Genetic risk factors

Genetic risk in Birt-Hogg-Dubé syndrome comes from changes in a single gene, FLCN, which disrupt cell-growth signals. The condition follows an autosomal dominant pattern, so one altered copy can be enough to cause it. Features often vary within families, and some people are identified only after a relative is diagnosed. Some risk factors are inherited through our genes.

• FLCN gene change: Pathogenic changes in the FLCN gene reduce folliculin function and drive Birt-Hogg-Dubé syndrome. Folliculin helps regulate cell growth signals, so loss of function can contribute to skin bumps, lung cysts, and kidney tumors.

• Autosomal dominant pattern: One altered FLCN copy is enough to cause the condition. Each child of an affected parent has a 50% (1 in 2) chance to inherit the variant.

• Variable penetrance: Not everyone with an FLCN variant shows the same features or timing. Signs may appear later in adulthood, so an apparently unaffected parent can still carry the variant. Risk is not destiny—it varies widely between individuals.

• De novo variants: Some people have a new FLCN variant with no prior family history. Their future children still face a 50% (1 in 2) chance to inherit it.

• Two-hit process: Kidney tumors often arise when the second, remaining FLCN copy in tumor cells is lost or damaged. This two-hit process explains how a germline variant increases renal cancer risk.

• Copy-number changes: Larger deletions or duplications that remove or repeat parts of FLCN can also cause the syndrome. These changes may be missed by basic sequencing and need tests that detect copy-number differences.

• Mutation hotspots: Certain regions, such as exon 11, are mutation hotspots reported across many populations. This helps laboratories focus testing but does not reliably predict severity.

• Genetic testing: Genetic testing for Birt-Hogg-Dubé syndrome searches for FLCN variants using sequencing plus deletion–duplication analysis. Finding a disease-causing variant confirms the diagnosis and guides who in the family needs surveillance.

• Family screening: Once a familial FLCN variant is known, first-degree relatives can be offered targeted testing. Testing clarifies who needs kidney and lung checks and who does not.

• Age-related onset: Many genetic features emerge in adulthood, including kidney tumors and lung cysts. Younger relatives who test positive may have no findings yet, so regular follow-up is still important.

• Founder effects: Shared ancestry in some regions has led to recurrent FLCN variants appearing in unrelated families. This can make Birt-Hogg-Dubé syndrome look clustered locally but does not change individual inheritance risk.

Transmission

Birt-Hogg-Dubé syndrome does not spread between people; you can’t catch it from someone else. It’s passed through families because of a change in a single gene, and if a parent has the syndrome, each child has a 50% chance of inheriting it, whether the parent is the mother or father. Sometimes Birt-Hogg-Dubé syndrome appears for the first time in a family due to a new gene change with no prior family history. Genetic transmission of Birt-Hogg-Dubé syndrome can be clarified with genetic testing and counseling for relatives.

When to test your genes

Consider genetic testing if you have multiple fibrofolliculomas (skin bumps), early or repeated lung collapses, or kidney tumors—especially if these cluster in your family. Test if a close relative has a confirmed FLCN variant, or if a doctor suspects BHDS based on imaging or exam. Results guide kidney screening, lung precautions, and family planning.

Looking at the long-term picture can be helpful. Most people with Birt-Hogg-Dubé syndrome (BHDS) live a normal lifespan, especially with regular monitoring and quick treatment when issues arise. The biggest day-to-day concerns are lung cysts that can lead to sudden lung collapse and an increased risk of certain kidney tumors. Many people ask, “What does this mean for my future?”, and the practical answer is that avoiding smoking, learning the early symptoms of BHDS-related lung collapse (like sudden one-sided chest pain and shortness of breath), and seeking urgent care can greatly reduce serious complications. Skin bumps on the face, neck, or upper body may be bothersome but are not dangerous; treatment is usually for comfort or appearance.

The most important long-term risk in BHDS is kidney cancer, which tends to appear earlier than average and can be multiple or in both kidneys. With planned screening—typically MRI or ultrasound at intervals set by your specialist—kidney tumors are often found when they’re small and highly treatable. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Overall mortality in BHDS is largely related to unmanaged kidney tumors; when tumors are detected early and treated, survival rates are excellent. Lung issues rarely affect long-term survival, but recurrent collapses can be disruptive, so strategies like pleurodesis may be discussed after repeat events.

Everyone’s journey looks a little different. Talk with your doctor about what your personal outlook might look like, including your kidney screening schedule, your plan if chest pain suggests a lung collapse, and options for skin care. If BHDS runs in your family, genetic testing can help clarify risks for relatives and guide screening ages. With ongoing care, many people maintain active lives, travel safely with precautions, and plan pregnancies and surgeries with their care team’s guidance.

Treatment for Birt-Hogg-Dubé syndrome focuses on monitoring and managing its main risks: lung cysts and collapsed lung, kidney tumors, and skin bumps. Regular kidney imaging (often MRI every 1–2 years) helps catch kidney cancers early, when surgery that saves as much kidney as possible is often the preferred option. For lung issues, doctors may suggest avoiding high-pressure activities like unpressurized flights or deep diving, teach signs of a collapsed lung, and consider procedures that lower the chance of repeat lung collapse if it happens. Skin bumps can be treated for comfort or appearance with approaches like laser therapy, electrosurgery, or topical treatments, though they may return over time. It’s natural to have questions about long-term follow-up, so ask your doctor about a personalized surveillance plan and whether your family members should consider genetic counseling and testing.

In most families, Birt-hogg-dube syndrome (also called Birt-Hogg-Dubé syndrome) happens because of a harmful change in a gene called FLCN, which helps cells keep their growth and repair in balance. The condition is passed down in a “one copy is enough” pattern (this is known medically as autosomal dominant), so each child of an affected parent has a 50% (1 in 2) chance of inheriting it, though occasionally it appears for the first time in a family. Even with the same gene change, people can have very different features—one relative might notice a few small skin bumps, while another has lung cysts or is found to have a kidney tumor on screening. When a doctor suspects it, a focused genetic test for FLCN can confirm the diagnosis and help guide care. Confirming the genetic inheritance of Birt-hogg-dube syndrome also helps identify which relatives may benefit from kidney imaging and lung precautions, and who can be reassured if they test negative. Genetic counselors can explain what the results mean for you and your family and help coordinate testing in a thoughtful, stepwise way.

Day to day, people with Birt-Hogg-Dubé syndrome who also have asthma or COPD may notice breathing symptoms feel tougher to manage, since lung cysts can make coughs, infections, or pressure changes more likely to trigger chest pain or a collapsed lung. Respiratory infections can “set things off,” so prompt treatment of colds and flu and smoking avoidance are especially important. Kidney issues can also intersect: if someone has diabetes, high blood pressure, or chronic kidney disease, these can influence how often kidney imaging is done and which treatments are safest when a tumor is found.

Some conditions share “underlying mechanisms,” such as Birt-Hogg-Dubé syndrome and tuberous sclerosis complex involving pathways that regulate cell growth, which is one reason their skin or lung features can look similar even though they are different disorders. There has been debate about a possible link with colorectal cancer; current evidence is mixed, so most guidelines suggest following standard bowel screening unless there’s a strong family history, in which case screening may start earlier. If you live with Birt-Hogg-Dubé syndrome and another long-term illness, talk with your doctor about how your conditions may influence each other, especially when planning surgeries, choosing imaging tests, or adjusting medicines.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.